 2
 
中文摘要 
 
關鍵詞：癌症，生化路徑網路，DNA 微陣列，基因次序結構，關連分析 
 
細胞內的生化路徑網路是一體的，雖然可分為基因調控網路、訊號傳遞網路、蛋白質
交互作用網路以及代謝網路等等的類別，每個類別又可分出具有特定特徵或功能的次網
路，次網路之間是相連的，存在交互作用，甚至不同類別的生化路徑次網路也有關連存在，
然而，針對癌症細胞中這種交互作用的分析文獻，目前仍未見到。 
本計畫在研究癌細胞中生化路徑次網路之間的交互作用，首先以目前已知的生化路徑
網路為基礎，重新整理並定義其次網路以及包含之基因，再利用不同細胞狀態具有不同的
基因網路次序結構，以DNA 微陣列數據來篩檢不同癌症細胞的特徵基因，最後利用關連分
析的方法，做生化路徑次網路與癌症細胞特徵基因的關連分析。 
 4
研究目的 
    細胞的癌化是基因變異累積的結果，使得基因的表現或功能改變，進而細胞內整體基
因間調控亦發生改變。癌細胞具有正常細胞所沒有的許多能力，例如；癌細胞的生長與細
胞分裂是不受控制的，正常細胞在某些情況下會啟動自殺機制，癌細胞失去這種機制，癌
細胞會刺激血管增生以獲得養分，癌細胞可以不斷做細胞分裂，癌細胞可以侵犯不同組織
的其他器官，這些能力使癌症病人失去生命。 
    癌症相關基因是研究癌症的診斷、形成與治療的關鍵，近幾年來，基因微陣列技術被
大量應用於癌症相關基因的研究，癌症相關基因的篩檢則是根據癌組織與正常組織之間，
基因的表現量是否有顯著差異，以各種統計分析的方法來檢定，例如；倍數改變法
（Fold-Change）(Schena et al., 1995; DeRisi et al., 1997; Chen et al., 1997)、t-檢定法（t-test）、
SAM(Tusher et al., 2001)以及 Mann-Whitney-Wilcoxon Rank Sum 檢定(Chen et al., 1997; 
Chambers et al., 1999)等方法，然而，這些方法找出來的癌症相關基因，在數目上通常偏低，
最近的相關文獻指出，癌症的產生是廣泛的基因變異的結果（Sjöblom et al., 2006）。我們
發展出利用基因表現的次序結構變異來做癌症分型的方法，並篩檢出癌症相關基因，結果
證明其在癌症分類的靈敏度優於其他方法（Liu et al., 2006），這表示次序結構變異的狀況，
更能顯示細胞狀態的變異，而篩檢出來的癌症相關基因（次序變異基因對）應更有代表性。 
     
 
 6
Unique total 196 
 
以上這些公用資料庫，雖然都有詳細的註解，但是與人相關的部分共有 59 個資料庫，仍
需再進一步整合。 
細胞內生化路徑網路是由許多次網路(sub-network)組成，每個次網路具有特定的特徵
或細胞功能，並且包含一群已知的特定基因，不同的癌症相關次網路可能不同，若以 Sm
表示第 m個次網路的基因群，其中包含 k 個基因，並以 Gn 表示以微陣列篩檢癌症 n所得
的癌症相關基因群，假設此微陣列總共包含 y 個基因，而細胞內全部基因數為 N，令 I=Sm
∩Gn 的基因數，則對 Sm 與 Gn 這兩群基因的分佈做關連分析(Haverty et al., 2004)，可計
算出 p-value： 
∑
=
−
−=−
k
Ii
N
k
yN
ik
y
i
C
CCvaluep  
p-value 越小，表示癌症 n 與次網路 m 有較高的關連性，類似的關連性分析亦可用費氏精
確檢定(Mlecnik et al., 2005)。關於癌症相關基因群的篩檢方法，主要是比較癌症細胞與
正常細胞的基因表現差異，做統計檢定，例如 t-檢定法（t-test）是最為常用的方法： 
21
21
11
nn
S
xx
T
p
e
+
−=  
2
)1()1(
21
2
22
2
11
−+
−+−=
nn
snsnS p  
其中 n1與 n2為癌症細胞與正常細胞的個別實驗次數， 1x 與 2x 分別代表基因 x在兩種細胞
狀態的平均表現量，t-檢定通常要求實驗數據呈現常態分佈，因此，原始基因表現量數據
須做對數轉換（xÆlog(x)），使接近常態分佈，若觀察值為 Te,obs，則 p-vale 為 Prob(|Te| > 
Te,obs)，一般定義 p-vale 小於 0.05 的基因為癌細胞相關基因。 
我們在發展癌症分型方法的過程中，提出了以基因網路的次序結構來來定義細胞狀態
並做癌症分型的方法(Liu et al., 2006)。當兩個基因 i 與 j 在 DNA 微陣列上的信號強度具有
顯著次序關係；即次序關係係數 rij大於某一顯著性門檻值，則建立這兩個基因的連線： 
 8
路內節點之間，與癌症相關的可能互動關係。 
 
 10
Reactome - Reactome KnowledgeBase  
GenMAPP - Gene MicroArray Pathway Profiler  
PathArt - Pathway Articulator  
GOLD.db - Genomics of Lipid-associated Disorders  
MetaCore - MetaCore pathway database  
 
C. Signaling Pathways 
CA1Neuron - Pathways of the hippocampal CA1 neuron  
Cancer Cell Map - The Cancer Cell Map  
GenMAPP - Gene MicroArray Pathway Profiler  
GOLD.db - Genomics of Lipid-associated Disorders  
Hedgehog - Hedgehog Signaling Pathway Database  
INOH - Integrating Network Objects with Hierarchies  
MetaCore - MetaCore pathway database  
PANTHER - PANTHER  
PathArt - Pathway Articulator  
Pathways Knowledge Base - Ingenuity Pathways Knowledge Base  
PhosphoSite - Cell Signaling Technology's PhosphoSite Database  
PID - CMAP Pathway Interaction Database  
Reactome - Reactome KnowledgeBase  
TRMP - Therapeutically Relevant Multiple Pathways Database  
 
D. Pathway Diagrams 
BioCarta - BioCarta Pathway Diagrams  
Hedgehog - Hedgehog Signaling Pathway Database  
INOH - Integrating Network Objects with Hierarchies  
PID - CMAP Pathway Interaction Database  
TRMP - Therapeutically Relevant Multiple Pathways Database  
 
E. Transcription Factors / Gene Regulatory Networks 
cisRED - Cis-regulatory element database  
ECRbase - Evolutionary conserved region database  
Hedgehog - Hedgehog Signaling Pathway Database   
HemoPDB - Hematopoiesis Promoter Database  
MAPPER - MAPPER  
microrna.org - Microrna.org target database  
TRED - Transcriptional Regulatory Element Database  
 12
 
 
人類蛋白質交互作用網路 
 
以上的網路是到目前為止，我們所整合出來最完整的生化路徑網路，若以三點以上成一子
群，則其中包含 56 個基因調控子網路以及 135 個蛋白質交互作用子網路，由於人類相關的
資料仍不夠豐富，真實的網路應該更為複雜。至於代謝反應的生物網路，則以 KEGG 的資
料庫為主，並針對其既有之分類為標準，作為後續癌症相關代謝網路分析的依據。 
 
二、微陣列數據資料庫來源 
我們使用 Oncomine database 作為微陣列基因表現的數據來源(Rhodes et al., 2004)，這
是專門提供作為癌症基因體研究的資料庫，其中包含 18,740 個 DNA 微陣列實驗，約
58,000,000 筆以上的基因表現數據。Oncomine database 蒐集的這些微陣列資料並不提供直
接下載，但是有提供其來源可以作為蒐集資料的線索，其中包含 cDNA 微陣列數據與寡核
甘酸微陣列數據。相關的人類癌症微陣列實驗數據來源如下表： 
 
Database Web site Reference 
ArrayExpress http://www.ebi.ac.uk/arrayexpress Brazma et al., 2005 
GeneNote http://genecards.weizmann.ac.il/genenote/ Shmueli et al., 2003 
 14
Ductal Breast Carcinoma Human Genome U133 Plus 2.0 Array Richardson et al. 
Fibroadenoma Sorlie Sorlie et al. 
Invasive Breast Carcinoma Agilent Human Genome 44K Finak et al. 
Invasive Lobular Breast Carcinoma Human Genome U133 Plus 2.0 Array Turashvili et al. 
Invasive Mixed Breast Carcinoma Radvanyi Radvanyi et al. 
Lobular Breast Carcinoma Zhao Zhao et al. 
4 Cervical Cancer   Human Genome U133 Plus 2.0 Array Pyeon et al. 
5 
Gastrointestinal 
Cancer 
Barrett's Esophagus Hao Esophagus Hao et al. 
Cecum Adenocarcinoma Human Genome U133 Plus 2.0 Array Kaiser et al. 
Colon Adenocarcinoma GPL4811 Ki et al. 
Colon Adenoma Human Genome U133 Plus 2.0 Array Sabates-Bellver et al.
Colon Carcinoma Zou Zou et al. 
Colon Mucinous Adenocarcinoma Human Genome U133 Plus 2.0 Array Kaiser et al. 
Colorectal Adenoma GPL3408 Gaspar et al. 
Colorectal Carcinoma Graudens Graudens et al. 
Diffuse Gastric Adenocarcinoma Chen Chen et al. 
Esophageal Adenocarcinoma Hao Hao et al. 
Gastric Intestinal Type Adenocarcinoma Chen Chen et al. 
Gastric Mixed Adenocarcinoma Chen Chen et al. 
Rectal Adenocarcinoma Human Genome U133 Plus 2.0 Array Kaiser et al. 
Rectal Adenoma Human Genome U133 Plus 2.0 Array Sabates-Bellver et al.
Rectal Mucinous Adenocarcinoma Human Genome U133 Plus 2.0 Array Kaiser et al. 
Rectosigmoid Adenocarcinoma Human Genome U133 Plus 2.0 Array Kaiser et al. 
6 
Head and Neck 
Cancer 
Floor of the Mouth Carcinoma Human Genome U133 Plus 2.0 Array Pyeon et al. 
Head and Neck Squamous Cell Carcinoma Human Genome U133A Array Ginos et al. 
Hypopharyngeal Squamous Cell Carcinoma Human Genome U133A Array Schlingemann et al.
Oral Cavity Carcinoma Human Genome U133 Plus 2.0 Array Pyeon et al. 
Oral Cavity Squamous Cell Carcinoma Human Genome U133A Array Toruner et al. 
Oropharyngeal Carcinoma Human Genome U133 Plus 2.0 Array Pyeon et al. 
Salivary Gland Adenoid Cystic Carcinoma Human Genome U95A-Av2 Array Frierson et al. 
Thyroid Gland Carcinoma Human Genome U95A-Av2 Array Huang et al. 
Tongue Carcinoma Human Genome U133 Plus 2.0 Array Pyeon et al. 
Tongue Squamous Cell Carcinoma Human Genome U133 Plus 2.0 Array Ye et al. 
Tonsillar Carcinoma Human Genome U133 Plus 2.0 Array Pyeon et al. 
7 Kidney Cancer 
Chromophobe Renal Cell Carcinoma Human Genome U133 Plus 2.0 Array Yusenko et al. 
Clear Cell Renal Cell Carcinoma Human Genome U133 Plus 2.0 Array Yusenko et al. 
Clear Cell Sarcoma of the Kidney Human Genome U133A Array Cutcliffe et al. 
Granular Renal Cell Carcinoma Higgins Higgins et al. 
Hereditary Clear Cell Renal Cell Carcinoma Human Genome U133A Array Beroukhim et al. 
 16
Smoldering Myeloma Human Genome U133 Plus 2.0 Array Zhan et al. 
14 Ovarian Cancer 
Ovarian Adenocarcinoma HumanGeneFL Array Welsh et al. 
Ovarian Clear Cell Adenocarcinoma 
Human Genome U95A-Av2 Array/Human 
Genome U95B Array/Human Genome U95C 
Array/Human Genome U95D Array/Human 
Genome U95E Array Lu et al. 
Ovarian Endometrioid Adenocarcinoma 
Human Genome U95A-Av2 Array/Human 
Genome U95B Array/Human Genome U95C 
Array/Human Genome U95D Array/Human 
Genome U95E Array Lu et al. 
Ovarian Mucinous Adenocarcinoma 
Human Genome U95A-Av2 Array/Human 
Genome U95B Array/Human Genome U95C 
Array/Human Genome U95D Array/Human 
Genome U95E Array Lu et al. 
Ovarian Serous Adenocarcinoma 
Human Genome U95A-Av2 Array/Human 
Genome U95B Array/Human Genome U95C 
Array/Human Genome U95D Array/Human 
Genome U95E Array Lu et al. 
Ovarian Serous Cystadenocarcinoma Human Genome U133A Array 
http://cancergenome.
nih.gov/  
15 Pancreatic Cancer 
Pancreatic Adenocarcinoma Iacobuzio-Donahue  
Iacobuzio-Donahue 
et al. 
Pancreatic Carcinoma Human Genome U133A Array Segara et al. 
Pancreatic Ductal Adenocarcinoma 
Human Genome U133A Array/Human Genome 
U133B Array Ishikawa et al. 
Pancreatic Intraepithelial Neoplasia Buchholz Pancreas Buchholz et al. 
Pancreatitis HumanGeneFL Array Logsdon et al. 
16 Prostate Cancer 
Benign Prostatic Hyperplasia Tomlins Tomlins et al. 
Prostate Adenocarcinoma 
Human Genome U133A Array/Human Genome 
U133B Array Vanaja et al. 
Prostate Carcinoma Human Genome U133 Plus 2.0 Array Varambally et al. 
Prostatic Intraepithelial Neoplasia Tomlins Tomlins et al. 
17 Sarcoma 
Dedifferentiated Liposarcoma Human Genome U133A Array Detwiller et al. 
Fibrosarcoma Human Genome U133A Array Detwiller et al. 
Leiomyosarcoma Human Genome U133A Array Detwiller et al. 
Malignant Fibrous Histiocytoma Human Genome U133A Array Detwiller et al. 
Pleomorphic Liposarcoma Human Genome U133A Array Detwiller et al. 
Round Cell Liposarcoma Human Genome U133A Array Detwiller et al. 
Synovial Sarcoma Human Genome U133A Array Detwiller et al. 
Uterine Corpus Leiomyosarcoma HumanGeneFL Array Quade et al. 
18 Other Cancer Actinic (Solar) Keratosis Human Genome U133A Array Nindl et al. 
 18
( )
⎩⎨
⎧
≤
>−=−
−
−−=
+
=
+∑
isjs
isjsisjs
isjs
N
s
isjs
ji
xx
xxxx
xx
xxN
xx
0
][
][
1
1 minmax
γ
 
上式中 isx 是實驗樣本 s 中基因 i 的表現信號強度；N 為樣本總數； maxx 與 minx 則為實驗樣
本中最大與最小基因表現信號強度。次序結構網路是一有向圖(directed graph)，連線 i → j
意味著基因 i 的信號強度比基因 j 來得低，所以當某一個基因有很高的由內向外連線，表
示這個基因有相對較低的表現信號強度；當某一個基因有很高的由外向內連線表示這個基
因有相對較高的表現信號強度。因為我們不知道此次序關係係數 rij的分佈，因此，門檻值
的決定採用隨機取樣測試過程：(a) 隨機自各個實驗樣本中選取一對基因構成一組基因
對，重複此過程 5000 次；(b) 對於這些隨機選取的各組基因對，分別計算次序關係係數 pγ  
(p = 1, 2, … , 5000)；(c) 由上述可以獲得一個次序關係係數的分布，以這個次序關係係數
分布的顯著水平 1% (P < 0.01)做為建構次序結構網路的門檻值。 
根據以上的演算法分別建立癌症以及與之相對應的正常細胞的次序結構網路，比較兩
個次序結構，其中有次序關係變異的連線與其兩端的基因，即為癌症相關基因。 
我們所收集的微陣列資料集有些是同類型癌症但是實驗平台或環境不同，若相同基因
對在不同平台的實驗有不一致的次序關係變異，則分別針對 i → j 與 j →i 在癌細胞與正
常細胞的 r 比值，先轉換為 ln(r 比值)，再利用 meta-analysis (Whitehead et al., 1991)來檢定
其是否顯著，並確認其次序關係變異是否存在，只要 i → j 與 j →i 其中之一的 ln(r 比值)
是顯著的，即認定其次序關係變異存在，其兩端的基因，即為癌症相關基因。 
     
四、癌症相關生化路徑次網路的關連性分析 
利用次序關係變異所篩檢出來的癌症相關基因，對應到整個生物網路（包含基因調空
網路、蛋白質交互作用網路以及代謝網路），並延伸其連結至下一層，定義為癌症相關生
化網路，計算其拓樸性質並探討其可能存在的次網路。探討的基本拓樸性質如下： 
1. Degree：自由度；是網路上節點的連線數量。這裡的連線數量在次序結構網路中，
指的是向外連線與向內連線的總和。 
2. Betweenness：居間度；是度量某節點被其他任兩節點間，最短路徑通過之次數。 
 20
結果與討論 
 
一、各類型癌症之間的相關性網路 
我們利用超幾何分佈(hypergeometric probability)來評估各類型癌症之間的相關程度，
若兩種癌症的顯著相關基因數為 Nr 與 Nq，細胞內的基因總數為 N，且兩種類行癌症的特
徵基因交集數為 Nc，則兩類型癌症相關程度的 p-value 計算如下式： 
∑
=
−
−=
Nq
Nci
Nq
N
iNq
NrN
i
Nr
val C
CCP  
則相關性可定義如下： 
)ln( valedge PWeight −=  
若兩癌症類型間的 Pval小於 0.01 既建立其連結關係，Weightedge即為此連結的權重，如下圖： 
 
結果顯示；同類型但是不同亞型的癌症的確較易聚在一起，但是有些不同類型的癌症
反而比同類型癌症更有相關性，這表示不同類型的癌症有可能具有相同的生物網路模
組或特徵基因，這表示其成癌的過程可能類似，在藥物治療上，可能也會有類似的反
應，甚至可推論；相同的癌症藥物，也許可以治療不同類型的癌症，這個現象仍有待
進一步加以探討。我們亦發現有兩小群的癌症沒有與其他癌症有顯著的關連，分別為
黑色素瘤與神經膠質母細胞瘤。圖中的編號與各類型癌症的對照表如下表： 
 22
Rectal Adenocarcinoma 5.13 
Rectal Adenoma 5.14 
Rectal Mucinous Adenocarcinoma 5.15 
Rectosigmoid Adenocarcinoma 5.16 
Head and Neck Cancer 
Floor of the Mouth Carcinoma 6.1 
Head and Neck Squamous Cell Carcinoma 6.2 
Hypopharyngeal Squamous Cell Carcinoma 6.3 
Oral Cavity Carcinoma 6.4 
Oral Cavity Squamous Cell Carcinoma 6.5 
Oropharyngeal Carcinoma 6.6 
Salivary Gland Adenoid Cystic Carcinoma 6.7 
Thyroid Gland Carcinoma 6.8 
Tongue Carcinoma 6.9 
Tongue Squamous Cell Carcinoma 6.10 
Tonsillar Carcinoma 6.11 
Kidney Cancer 
Chromophobe Renal Cell Carcinoma 7.1 
Clear Cell Renal Cell Carcinoma 7.2 
Clear Cell Sarcoma of the Kidney 7.3 
Granular Renal Cell Carcinoma 7.4 
Hereditary Clear Cell Renal Cell Carcinoma 7.5 
Non-Hereditary Clear Cell Renal Cell Carcinoma 7.6 
Papillary Renal Cell Carcinoma 7.7 
Renal Wilms Tumor 7.8 
Leukemia 
Acute Adult T-Cell Leukemia/Lymphoma 8.1 
Acute Myeloid Leukemia 8.2 
B-Cell Acute Lymphoblastic Leukemia 8.3 
Chronic Adult T-Cell Leukemia/Lymphoma 8.4 
Chronic Lymphocytic Leukemia 8.5 
Hairy Cell Leukemia 8.6 
T-Cell Acute Lymphoblastic Leukemia 8.7 
T-Cell Prolymphocytic Leukemia 8.8 
Liver Cancer 
Cirrhosis 9.1 
Focal Nodular Hyperplasia of the Liver 9.2 
Hepatocellular Adenoma 9.3 
Hepatocellular Carcinoma 9.4 
Liver Cell Dysplasia 9.5 
Lung Cancer 
Large Cell Lung Carcinoma 10.1 
Lung Adenocarcinoma 10.2 
Lung Carcinoid Tumor 10.3 
Small Cell Lung Carcinoma 10.4 
 24
Uterine Corpus Leiomyosarcoma 17.8 
Other Cancer 
Actinic (Solar) Keratosis 18.1 
Adrenal Cortex Adenoma 18.2 
Adrenal Cortex Carcinoma 18.3 
Embryonal Carcinoma 18.4 
Endometrial Endometrioid Adenocarcinoma 18.5 
Familial Parathyroid Hyperplasia  18.6 
Malignant Glioma 18.7 
Mixed Germ Cell Tumor 18.8 
Non-Familial Multiple Gland Neoplasia 18.9 
Parathyroid Gland Adenoma 18.10 
Parathyroid Hyperplasia 18.11 
Pleural Malignant Mesothelioma 18.12 
Primitive Neuroectodermal Tumor 18.13 
Renal Oncocytoma 18.14 
Seminoma 18.15 
Skin Basal Cell Carcinoma 18.16 
Skin Squamous Cell Carcinoma 18.17 
Teratoma 18.18 
Testicular Intratubular Germ Cell Neoplasia 18.19 
Testicular Seminoma 18.20 
Testicular Teratoma 18.21 
Testicular Yolk Sac Tumor 18.22 
Uterine Corpus Leiomyoma 18.23 
Vulvar Intraepithelial Neoplasia 18.24 
Yolk Sac Tumor 18.25 
 
二、癌症特徵網路與次網路 
利用次序結構差異篩選出來的癌症相關基因(p-value <0.01)，我們直接將這些基因以及
其產物蛋白質對應到人類基因調控網路以及蛋白質交互作用網路，並延伸其連結的第一
層，定義為癌症特徵基因調控網路與特徵蛋白質交互作用網路（附錄一）。例如下圖分別為
肺腺癌(Lung Adenocarcinoma)的特徵基因調控網路與特徵蛋白質交互作用網路： 
 
 26
 <Degree> <Betweenness> <Closeness> 
肺腺癌特徵基因調控網路 1.25 1.25 0.15 
肺腺癌特徵蛋白質交互作用網路 1.56 1.51 0.05 
 
除了基本的拓樸特性外，針對這些特徵網路，我們利用 MLC 演算法(Enright et al., 2002)
來計算其可能存在的次網路。MLC 演算法是模擬流量在網路中的隨機流動過程，並產生出
可能存在的次網路結構，這些次網路可能是癌症基因調控模組或者是蛋白質交互作用模
組。以肺腺癌特徵蛋白質交互作用網路為例，其次網路結構如下： 
 
 
三、癌症特徵次網路與癌症的關連性 
若以 S 表示某個次網路的基因群，其中包含 k 個基因，以 G 表示以次序結構變異所
篩檢出來的癌症相關基因群，假設此微陣列總共包含 y 個基因，而細胞內全部基因數為 N，
令 I=S∩G 的基因數，則對 S 與 G 這兩群基因的分佈做關連分析(Haverty et al., 2004)，可
計算出 p-value： 
∑
=
−
−=
k
Ii
N
k
yN
ik
y
i
val C
CCp  
pvalue越小，表示此癌症 G 與次網路 S 有較高的關連性，我們定義其關連強度為 1-pvalue 
我們計算了癌症相關的次網路以及其關連強度，結果發現其關連度往往不具統計上的
 28
計畫成果自評 
本計畫為兩年之計畫，在計畫進行過程中，教育學生具備一定之能力參與計畫，
是最困難的一環。本計畫的第一年主要在整理生物網路資料庫以及蒐集癌症相關的微
陣列實驗數據，同時教育學生培養參與計畫的能力，第二年則開始進入計畫的主要部
分--癌症相關生物網路探勘，由於人類相關的生物網路資料仍不豐富，因此，最後的結
果仍有很大的發展空間，相信隨著公用資料庫的資料量增加，未來應能有很大的改善，
另一個問題是，癌症特徵基因的選取，以次序結構變異取代統計檢定，雖然可以得到
較多的基因數，這在生物網路建立上是很有幫助的，但是，為了避免可能的偽陽性，
我們提高了篩選的標準(p-value < 0.01)。最後；我們利用 MLC 演算法定義出基因調控
次網路以及蛋白質交互作用次網路，代謝次網路則依據 KEGG 的分類法，並篩選出癌
症相關的次網路，關於次網路的交互作用，我們往往得到無交互作用的結果，可能原
因是建立的網路並不夠完整以及人類生化網路（除了代謝網路外）基因數太少，未來
應持續探討。 
本計畫已初步完成癌症相關生物網物建立與分析，有待未來進一步探討，個人相
信以綜觀所有類型癌症的角度來看待癌症，而非僅僅探討個別癌症，在未來應該能有
一些新的發現。 
 30
 
Bhattacharjee, A., Richards, W.G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., 
Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E.J., Lander, E.S., Wong, W., Johnson, B.E., 
Golub, T.R., Sugarbaker, D.J., and Meyerson, M. (2001) Classification of human lung carcinomas 
by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U 
S A, 98, 13790-13795. 
 
Bommert, K., Bargou, R.C., and Stuhmer, T. (2006) Signalling and survival pathways in multiple 
myeloma. Eur. J. Cancer, 42, 1574-80 
 
Buchholz, M., Braun, M., Heidenblut, A., Kestler. H.A., Klöppel, G., Schmiegel, W., Hahn, S.A., 
Lüttges, J., and Gress, T.M. (2005) Transcriptome analysis of microdissected pancreatic 
intraepithelial neoplastic lesions. Oncogene, 24, 6626-6636. 
 
Bussemaker, H.J., Li, H., and Siggia, E.D. (2001) Regulatory element detection using correlation 
with expression. Nature Genet., 27, 167-171. 
 
Brazma, A., Parkinson, H., Sarkans, U., Shojatalab, M., Vilo, J., Abeygunawardena, N., 
Holloway, E., Kapushesky, M., Kemmeren, P., Garcia Lara, G., Oezcimen, A., Sansone, S., 
Rocca-Serra, P. (2005) ArrayExpress—a public repository for microarray gene expression data 
at the EBI. Nucleic Acids Research, 33, D553-D555. 
 
Bussemaker, H.J., Li, H., and Siggia, E.D. (2001) Regulatory element detection using correlation 
with expression. Nature Genet., 27, 167-171. 
 
Chambers, A., Angulo, A., Amaratunga, D., Guo, H., Jiang, Y., Wan, J.S., Bittner, A., Frueh, K., 
Jackson, M.R., Peterson, P.A., Erlander, M.G., and Ghazal, P. (1999) DNA microarrays of the 
complex human cytomegalovirus genome: Profiling kinetic class with drug sensitive viral gene 
expression. J. Virol., 73, 5757-5766. 
 
Chen, H.C., Lee, H.C., Lin, T.Y., Li, W.H., and Chen, B.S. (2004) Quantitative characterization 
of the transcriptional regulatory network in the yeast cell cycle. Bioinformatics, 20, 1914-1927. 
 
Chen, J.J., Lin, Y.C., Yao, P.L., Yuan, A., Chen, H.Y., Shun, C.T., Tsai, M.F., Chen, C.H. and 
Yang, P.C. (2005) Tumor-associated macrophages: the double-edged sword in cancer progression. 
J. Clin. Oncol. 23, 953-964. 
 
Chen, J.J.W., Peck, K., Hong, T.M., Yang, S.C., Sher, Y.P., Shih, J.Y., Wu, R., Wu, C.W. and 
Yang, P.C. (2001) Global analysis of gene expression in invasion by a lung cancer model. Cancer 
Res. 61, 5223-5230. 
 
 32
mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic 
leukemia with inv(14)(q11q32). Leukemia, 21, 2153-2163.  
 
Dyrskjøt, L., Kruhøffer, M., Thykjaer, T., Marcussen, N., Jensen, J.L., Møller, K., and Ørntoft, 
T.F. (2004) Gene expression in the urinary bladder: a common carcinoma in situ gene expression 
signature exists disregarding histopathological classification. Cancer Res., 64, 4040-4048. 
 
Edgar, R., Domrachev, M., and Lash, A.E. (2002) Gene Expression Omnibus: NCBI gene 
expression and hybridization array data repository. Nucleic Acids Research, 30, 207-210. 
 
Elfilali, A., Lair, S., Verbeke, C., La Rosa, P., Radvanyi, F. and Barillot, E. (2006) ITTACA: a 
new database for integrated tumor transcriptome array and clinical data analysis. Nucleic Acids 
Research, 34, D613-D616. 
 
Enright, A.J., Van Dongen, S., and Ouzounis, C.A. (2002) An efficient algorithm for large-scale 
detection of protein families, Nucleic Acids Research, 30, 1575-1584.. 
 
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, 
G., Meterissian, S., Omeroglu, A., Hallett, M., and Park, M. (2008) Stromal gene expression 
predicts clinical outcome in breast cancer. Nat Med., 14, 518-527. 
 
French, P.J., Swagemakers, S.M., Nagel, J.H., Kouwenhoven, M.C., Brouwer, E., van der Spek, 
P., Luider, T,M,, Kros, J.M., van den Bent, M.J., and Sillevis Smitt, P.A. (2005) Gene expression 
profiles associated with treatment response in oligodendrogliomas. Cancer Res., 65, 
11335-11344. 
 
Frierson, H.F., Jr, El-Naggar, A.K., Welsh, J.B., Sapinoso, L.M., Su, A.I., Cheng, J., Saku, T., 
Moskaluk, C.A., Hampton, G.M. (2002) Large scale molecular analysis identifies genes with 
altered expression in salivary adenoid cystic carcinoma. Am J Pathol., 161, 1315-1323. 
 
Garber, M.E., Troyanskaya, O.G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, 
M., van de Rijn, M., Rosen, G.D., Perou, C.M., Whyte, R.I., Altman, R.B., Brown, P.O., Botstein, 
D., and Petersen, I. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc Natl 
Acad Sci U S A, 98, 13784-13789.  
 
Gaspar, C., Cardoso, J., Franken, P., Molenaar, L., Morreau, H., Möslein, G., Sampson, J., Boer, 
J.M., de Menezes, R.X., and Fodde, R. (2008) Cross-species comparison of human and mouse 
intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven 
tumorigenesis. Am J Pathol., 172, 1363-80.  
 
Gisiger, T. (2001) Scale invariance in biology: coincidence or footprint of a universal mechanism? 
 34
 
Haverty, P.M., Hansen, U., and Weng, Z. (2004) Computational inference of transcriptional 
regulatory networks from expression proÆling and transcription factor binding site identification. 
Nucleic Acids Research, 32, 179-188. 
 
Haverty, P., Weng, Z., Best, N., Auerback, K., Hsiao, L., Jensen, R., Gullans, S. (2002) 
HugeIndex: a database with visualization tools for high-density oligonucleotide array data from 
normal human tissues. Nucleic Acids Research, 30, 214-217 
 
Huang, Y., Prasad, M., Lemon, W.J., Hampel, H., Wright, F.A., Kornacker, K., LiVolsi, V., 
Frankel, W., Kloos, R.T., Eng, C., Pellegata, N.S., and de la Chapelle, A. (2001) Gene expression 
in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A, 98, 
15044-15049. 
 
Iacobuzio-Donahue, C.A., Maitra, A., Olsen, M., Lowe, A.W., van Heek, N.T., Rosty, C., Walter, 
K., Sato, N., Parker, A., Ashfaq, R., Jaffee, E., Ryu, B., Jones, J., Eshleman, J.R., Yeo, C.J., 
Cameron, J.L., Kern, S.E., Hruban, R.H., Brown, P.O., and Goggins, M. (2003) Exploration of 
global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J 
Pathol., 162, 1151-1162. 
 
Ishikawa, M., Yoshida, K., Yamashita, Y., Ota, J., Takada, S., Kisanuki, H., Koinuma, K., Choi, 
Y.L., Kaneda, R., Iwao, T., Tamada, K., Sugano, K., and Mano, H. (2005) Experimental trial for 
diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal 
cells. Cancer Sci., 96, 387-393. 
 
Jeong, H., Mason, S.P., Barabasi, A.L., and Oltvai, Z.N. (2001) Lethality and centrality in 
protein networks. Nature, 411, 41–41. 
 
Kaiser, S., Park, Y.K., Franklin, J.L., Halberg, R.B., Yu, M., Jessen, W.J., Freudenberg, J., Chen, 
X., Haigis, K., Jegga, A.G., Kong, S., Sakthivel, B., Xu, H., Reichling, T., Azhar, M., Boivin, G.P., 
Roberts, R.B., Bissahoyo, A.C., Gonzales, F., Bloom, G.C., Eschrich, S., Carter, S.L., Aronow, 
J.E., Kleimeyer, J., Kleimeyer, M., Ramaswamy, V., Settle, S.H., Boone, B., Levy, S., Graff, J.M., 
Doetschman, T., Groden, J., Dove, W.F., Threadgill, D.W., Yeatman, T.J., Coffey, R.J. and Jr, 
Aronow, B.J. (2007) Transcriptional recapitulation and subversion of embryonic colon 
development by mouse colon tumor models and human colon cancer. Genome Biol., 8, R131.  
 
Katoh, Y., and Katoh, M. (2005) Hedgehog signaling pathway and gastric cancer. Cancer Biol. 
Ther., 4, 1050-1054. 
 
Keller, J., Gader, P., and Hocaoglu, A.K. (2000) Fuzzy Integrals in Image Processing and 
Recognition. Fuzzy Measures and Integrals: Theory and Applications, pp. 435-466. 
 36
pathways. Nucleic Acids Research, 33, W633-W637. 
 
Morrison, C., Farrar, W., Kneile, J., Williams, N., Liu-Stratton, Y., Bakaletz, A., Aldred, M.A., 
and Eng, C. (2004) Molecular classification of parathyroid neoplasia by gene expression profiling. 
Am J Pathol., 165, 565-576. 
 
Mutter, G.L., Baak, J.P., Fitzgerald, J.T., Gray, R., Neuberg, D., Kust, G.A., Gentleman, R., 
Gullans, S.R., Wei, L.J., and Wilcox, M. (2001) Global expression changes of constitutive and 
hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol., 83, 
177-185. 
 
Pomeroy, S.L., Tamayo, P., Gaasenbeek, M., Sturla, L.M., Angelo, M., McLaughlin, M.E., Kim, 
J.Y., Goumnerova, L.C., Black, P.M., Lau, C., Allen, J.C., Zagzag, D., Olson, J.M., Curran, T., 
Wetmore, C., Biegel, J.A., Poggio, T., Mukherjee, S., Rifkin, R., Califano, A., Stolovitzky, G., 
Louis, D.N., Mesirov, J.P., Lander, E.S., and Golub, T.R. (2002) Prediction of central nervous 
system embryonal tumour outcome based on gene expression. Nature, 415, 436-442. 
 
Popescu, M., Keller, J.M., and Mitchell, J.A. (2006) Fuzzy Measures on the Gene Ontology for 
Gene Product Similarity. IEEE/ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND 
BIOINFORMATICS, 3, 263-274. 
 
Pyeon, D., Newton, M.A., Lambert, P.F., den Boon, J.A., Sengupta, S., Marsit, C.J., Woodworth, 
C.D., Connor, J.P., Haugen, T.H., Smith, E.M., Kelsey, K.T., Turek, L.P., and Ahlquist, P. (2007) 
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human 
papillomavirus-negative head/neck and cervical cancers. Cancer Res., 67, 4605-4619. 
 
Quade, B.J., Wang, T.Y., Sornberger, K., Dal Cin, P., Mutter, G.L., and Morton, C.C. (2004) 
Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes 
Chromosomes Cancer, 40, 97-108. 
 
Radvanyi, L., Singh-Sandhu, D., Gallichan, S., Lovitt, C., Pedyczak, A., Mallo, G., Gish, K., 
Kwok, K., Hanna, W., Zubovits, J., Armes, J., Venter, D., Hakimi, J., Shortreed, J., Donovan, M., 
Parrington, M., Dunn, P., Oomen, R., Tartaglia, J., and Berinstein, N.L. (2005) The gene 
associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. 
Proc Natl Acad Sci U S A, 102, 11005-11010.  
 
Rhodes, D.R. et al. (2004) OCOMINE: a cancer microarray database and integrated data mining 
platform. Neoplasia, 6, 1-6. 
 
Rhodes, D.R., Kalyana-Sundaram, S., Mahavisno, V., Barrette, T.R., Ghosh, D., and Chinnaiyan, 
A.M. (2005) Mining for regulatory programs in the cancer transcriptome. Nature Genet., 37, 
 38
Almashanu, L., Madi, A., Sirota, A., Kats, P., Chalifa-Caspi, V., Safran, M., Lancet, D. (2003) 
Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 
21 and HORDE. Nucleic Acids Research, 31, 142-146. 
 
Sjöblom et al., (2006) The consensus coding sequences of human breast and colorectal cancers. 
Science, 314, 268-274. 
 
Skotheim, R.I., Lind, G.E., Monni, O., Nesland, J.M., Abeler, V.M., Fosså, S.D., Duale, N., 
Brunborg, G., Kallioniemi, O., Andrews, P.W., and Lothe, R.A. (2005) Differentiation of human 
embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal 
development. Cancer Res., 65, 5588-5598. 
 
Sørlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B., 
van de Rijn, M., Jeffrey, S.S., Thorsen, T., Quist, H., Matese, J.C., Brown, P.O., Botstein, D., 
Eystein Lønning, P., and Børresen-Dale, A.L. (2001) Gene expression patterns of breast 
carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A, 98, 
10869-10874. 
 
Storey,J.D., and Tibshirani,R. (2003) Statistical significance for genomewide studies. Proc. Natl 
Acad. Sci. USA, 100, 9440–9445. 
 
Strogatz, S.H. (2001) Exploring complex networks. Nature, 410, 268–276. 
 
Storz, M.N., van de Rijn, M., Kim, Y.H., Mraz-Gernhard, S., Hoppe, R.T., and Kohler, S. (2003) 
Gene expression profiles of cutaneous B cell lymphoma. J Invest Dermatol., 120, 865-870. 
 
Su, L.J., Chang, C.W., Wu, Y.C., Chen, K.C., Lin, C.J., Liang, S.C., Lin, C.H., Whang-Peng, J., 
Hsu, S.L., Chen, C.H., and Huang, C.Y. (2007) Selection of DDX5 as a novel internal control for 
Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics, 1, 
140. 
 
Sun, L., Hui, A.M., Su, Q., Vortmeyer, A., Kotliarov, Y., Pastorino, S., Passaniti, A., Menon, J., 
Walling, J., Bailey, R., Rosenblum, M., Mikkelsen, T., and Fine, H.A. (2006) Neuronal and 
glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell, 9, 287-300. 
 
Talantov, D., Mazumder, A., Yu, J.X., Briggs, T., Jiang, Y., Backus, J., Atkins, D., and Wang, Y. 
(2005) Novel genes associated with malignant melanoma but not benign melanocytic lesions. 
Clin Cancer Res., 11, 7234-7242. 
 
Tomlins, S.A., Mehra, R., Rhodes, D.R., Cao, X., Wang, L., Dhanasekaran, S.M., 
Kalyana-Sundaram, S., Wei, J.T., Rubin, M.A., Pienta, K.J., Shah, R.B., and Chinnaiyan, A.M. 
 40
X. (2008) Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics, 6, 69. 
 
Yeoh, E.-J., et al. (2002) Classification, subtype discovery, and prediction of outcome in 
pediatric lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1, 133–143. 
 
Yugi, K., Nakayama, Y., Kojima, S., Kitayama, T., and Tomita, M. (2005) A microarray 
data-based semi-kinetic method for predicting quantitative dynamics of genetic networks. BMC 
Bioinformatics, 6, 299-315 
 
Yusenko, M.V., Kuiper, R.P., Boethe, T., Ljungberg, B., van Kessel, A.G., and Kovacs, G. (2009) 
High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal 
cell carcinomas and renal oncocytomas. BMC Cancer, 9, 152. 
 
Zhan, F., Hardin, J., Kordsmeier, B., Bumm, K., Zheng, M., Tian, E., Sanderson, R., Yang, Y., 
Wilson, C., Zangari, M., Anaissie, E., Morris, C., Muwalla, F., van Rhee, F., Fassas, A., Crowley, 
J., Tricot, G., Barlogie, B., and Shaughnessy, J. (2002) Global gene expression profiling of 
multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone 
marrow plasma cells. Blood, 99, 1745-1757. 
 
Zhan, F., Barlogie, B., Arzoumanian, V., Huang, Y., Williams, D.R., Hollmig, K., Pineda-Roman, 
M., Tricot, G., van Rhee, F., Zangari, M., Dhodapkar, M., and Shaughnessy, J.D. (2007) 
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is 
linked to good prognosis. Blood, 109, 1692-1700.  
 
Zhao, H., Langerød, A., Ji, Y., Nowels, K.W., Nesland, J.M., Tibshirani, R., Bukholm, I.K., 
Kåresen, R., Botstein, D., Børresen-Dale, A.L., and Jeffrey, S.S. (2004) Different gene expression 
patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell, 15, 2523-2536.  
 
Zou, T.T., Selaru, F.M., Xu, Y., Shustova, V., Yin, J., Mori, Y., Shibata, D., Sato, F., Wang, S., 
Olaru, A., Deacu, E., Liu, T.C., Abraham, J.M., and Meltzer, S.J. (2002) Application of cDNA 
microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer 
and normal colon. Oncogene, 21, 4855-4862. 
 42
 
Type:Bladder Cancer  Subtype:Stage 0is Bladder Urothelial Carcinoma 
 
 
 44
 
Type:Brain and CNS Cancer  Subtype:Anaplastic Astrocytoma 
 
 
 46
 
Type:Brain and CNS Cancer  Subtype:Anaplastic Oligodendroglioma 
 
 
 48
 
Type:Brain and CNS Cancer  Subtype:Atypical Teratoid/Rhabdoid Tumor 
 
 
 50
 
Type:Brain and CNS Cancer  Subtype:Desmoplastic Medulloblastoma 
 
 
 52
 
Type:Brain and CNS Cancer  Subtype:Glioblastoma 
 
 
 54
 
Type:Brain and CNS Cancer  Subtype:Oligoastrocytoma 
 
 
 56
 
Type:Brain and CNS Cancer  Subtype:Pilocytic Astrocytoma 
 
 
 58
 
Type:Brain and CNS Cancer  Subtype:Secondary Glioblastoma 
 
 
 60
 
Type:Breast Cancer  Subtype:Ductal Breast Carcinoma 
 
 
 62
 
Type:Breast Cancer  Subtype:Invasive Breast Carcinoma 
 
 
 64
 
Type:Breast Cancer  Subtype:Invasive Mixed Breast Carcinoma 
 
 
 66
 
Type:Leukemia  Subtype:Acute Adult T-Cell Leukemia/Lymphoma 
 
 
 68
 
Type:Leukemia  Subtype:B-Cell Acute Lymphoblastic Leukemia 
 
 
 70
 
Type:Leukemia  Subtype:Chronic Lymphocytic Leukemia 
 
 
 72
 
Type:Leukemia  Subtype:T-Cell Acute Lymphoblastic Leukemia 
 
 
 74
 
Type:Liver Cancer  Subtype:Cirrhosis 
 
 
 76
 
Type:Liver Cancer  Subtype:Hepatocellular Adenoma 
 
 
 78
 
Type:Liver Cancer  Subtype:Liver Cell Dysplasia 
 
 
 80
 
Type:Lung Cancer  Subtype:Lung Adenocarcinoma 
 
 
 82
 
Type:Lung Cancer  Subtype:Small Cell Lung Carcinoma 
 
 
出 席 會 議 報 告 表
會議名
稱
International Conference on Wavelet
Analysis and Pattern Recognition
會議地
點 香港
會議
時間
2008 年 8 月
29 日
15 時 00 分
會議主
持人
出席
人員
張培均
會議內
容
這次的會議是以共同作者的身份前往，發表的論文是模糊理論在分類上的應
用，在 Pattern Recognition的領域裡，這是一個新的議題，我們提出利用模糊積分
來整合分類特徵，以達到最佳分類精確度的演算法，這個方法目前廣泛應用在病
毒分類、病毒宿主預測、生醫訊號的時間序列分類以及 DNA微陣列的癌症分類上。
在與會過程中，經過相關的討論，我們瞭解到關於模糊測度的估計方法，與被預
測系統的特性具高度敏感性，分類特徵的選取在高度非線性系統往往不能以
Pearson’s 係數作為模糊測度，到目前為止，這依舊是一個沒有定論的議題。以模
糊積分來衡量不同估計特徵量之間的交互作用，是我未來研究癌症相關生化路徑
網路交互作用的主要方向。
與會三天中，聽取眾多學者的論文發表，獲益良多。
are described in section 7 and final section is for
conclusions and future works.
2. Four physicochemical properties of amino acids
There are four physicochemical quantities of acidity,
Van der waal volume, surface area and hydrophobicity in
the situation of single amino acid showed as Table 1 [2],
[3]
Table 1.
20 amino acids and its 4 physicochemical quantities
Amino
acid
Acidity
Van der
waal
Volume
Surface
area
HydroPh-
obicity
A 7.0 67 115 0.616
C 3.4 86 135 0.680
D 3.9 67 150 0.028
E 4.1 109 190 0.043
F 7.0 135 210 1.000
G 7.0 48 75 0.501
H 6.0 118 195 0.165
I 7.0 124 175 0.943
K 10.5 135 200 0.283
L 7.0 124 170 0.943
M 7.0 124 185 0.738
N 7.0 148 160 0.236
P 7.0 90 145 0.711
Q 7.0 114 180 0.251
R 12.5 167 225 0.000
S 7.0 73 115 0.359
T 7.0 93 140 0.450
V 7.0 105 155 0.825
W 7.0 163 255 0.878
Y 10.5 141 230 0.880
3. Hurst exponent
The Hurst exponent occurs in several areas of applied
mathematics, including fractals and chaos theory, long term
memory processes and spectral analysis [8]. Hurst exponent
estimation has been applied in areas ranging from
biophysics to computer networking. Estimation of the Hurst
exponent was originally developed in hydrology. However,
the modern techniques for estimating the Hurst exponent
comes from fractal mathematics.
Estimating the Hurst exponent for a data set provides a
measure of whether the data is a pure random walk or has
underlying trends.
The Hurst exponent (H) is a statistical measure used to
classify time series. H=0.5 indicates a random series while
H>0.5 indicates a trend reinforcing series. The larger the H
value is, the stronger the trend. Experiments with
backpropagation Neural Networks show that series with
large Hurst exponent can be predicted more accurately than
those with H value close to 0.50. Thus the Hurst exponent
provides a measure for predictability.
Three methods were used most often for the estimation
of the Hurst exponent: the R/S method, the
roughness–length (R–L) method and a variogram. The R/S
method (Hurst et al., 1965) [9] is commonly perceived as
the most suitable for the time series analysis, because it
presents the relationship between irregular (singular)
rescaled ranges, signal value and their local statistical
properties relative to the scale factor.
In this study R/S method is used. R/S method [10]
is based on empirical observations by Hurst and estimates
H are based on the R/S statistic. It indicates (asymptotically)
second-order self-similarity. H is roughly estimated through
the slope of the linear line in a log-log plot, depicting the
R/S statistics over the number of points of the aggregated
series. That is, given a time sequence of observations, tw
define the Series
   
1
, ,1
t
u
u
W t w w t 

   , (5)
Where
1
1
t
t
w w

 
  . (6)
Define
11
( ) max ( , ) min ( , )
tt
R W t W t
 
  

  (7)
and  2
1
1
( ) t
t
S w w

 
     (8)
In plotting
( )
log
( )
R
S


against log, we expect to
get a line whose slope determines the Hurst exponent.
4. Support vector machine (SVM), [11~14],
Given the training set of instance-labeled pairs
 , , 1,2,...,i ix y i N , where
 , 1, 1 , 1, 2,...,ni ix R y i N    (9)
The support vector machine (SVM) algorithm (Boser,
 
 
2 2
2
1
exp
, , 1, 2,...,
1 exp
N
ij ik i
ij k k j
i
x x xl l
j k n
x
 
     
   
       

Increment k; until 1 1
1
ˆ ˆ
ˆ ˆ
ˆ ˆ
n nk k
 
  
 
   
   
       
   
      
 
(24)
Then
 
 
ˆ ˆ1 1| 0.5
ˆ ˆ0 1| 0.5
i i i
i
i i i
if P P Y x
y
if P P Y x
   
  
(25)
6. SVM-Logistic regression classifier
In this paper, an improved hybrid classifier combining
SVM and logistic regression is proposed here.
First step, using the SVM classifier, we can find the
signed distance, ( )id x , between the point
 1 2, ,...,i i i inx x x x and the hyperplane in SUM,
Second step, to consider the sample data
 , , 1, 2,...,i id x y i N , using the simple logistic
regression to classify iy .
6.1 Mathematical formulas
Let 1 2, ...., , 1,2,...,i i in ix x x y i N be a sample data,
satisfying    1 2, ,..., , 0,1 ,ni i i in ix x x x R y   (26)
Using the above support vector machine (SVM)
algorithm, from equation (11), for any point nix R ,
we can obtain the signed distance as below
  ( ) 1i i id x w x b       (27)
6.2 Simple logistic regression classifier of the working
sample data
Let the working sample data  , , 1, 2,...,i id x y i N
satisfying   , 1,0i id x R y 
 ~ 1, , 1,2,...,i iY B p i N  (28)
The simple logistic regression model is denoted as
follows
   
1
1| , 1,2,...,
1 exp
i i i
i
P P Y d x i N
d x 
   
    
(29)
Similarly as multiple logistic regression classifier, we
can get log likelihood function, the estimated regression
coefficients of the simple logistic regression model and the
estimated simple logistic regression equation as follows:
    
     
1
1
, log 1 1 log
log 1 1
N
i i i i
i
N
i i i
i
l l y p y p
exp d x y d x

   


      
          


(30)
 
 
1ˆ ˆ 1|
ˆˆ1 exp
i i i
i
P P Y d x
d x 
  
    
(31)
12 2
2
2 2
1
2
ˆ ˆ
ˆ ˆ
k k
kk
l l l
ll l
   
 
 


                          
(32)
where
   1
1
1
1 exp
N
i
i i
l
y
d x  
     
       
 (33)
    1
1
1
1 exp
N
i i
i i
l
y d x
d x  
     
       
 (34)
 
 
2
2 2
1
exp
1 exp
N
i
i
i
d xl
d x
 
  
 
    
 (35)
  
 
2
2
2 2
1
exp
1 exp
N
i i
i
i
d x d xl
d x
 
  
   
    
 (36)
  
 
2 2
2
1
exp
1 exp
N
i i
i
i
d x d xl l
d x
 
   
  
     
 (37)
Increment k; until
1 1
ˆ ˆ
ˆ
kˆk
 

 
  
   
 
(38)
Then
 
 
ˆ ˆ1 1| 0.5
ˆ ˆ0 1| 0.5
i i i
i
i i i
if P P Y d x
y
if P P Y d x
   
  
(39)
7. Experiment and result
The sequence data of serotype H5 of Influenza A
algorithm for optimal margin classifiers”, In Fifth
Annual Workshop on Computational Learning
Theory, Pittsburgh, 1992. ACM.
[12] C. Cortes, and V. Vapnik,  “Support-vector
network”, Machine Learning, Vol. 20, pp. 273-297,
1995.
[13] V. Vapnik, The Nature of Statistical Learning
Theory. New York, NY. Springer-Verlay, 1995.
[14] C.-C. Chang, and C.-C. Lin, LIBSVM; a library for
support vector machine Software available at
http://www.csie.ntu.edu.tw/cjlin/libsvm, 2004
Physiochemical Constraints in Influenza A Hemagglutinin
Jiunn-I Shieh
Department of Information Science and Applications
Asia University, Taichun, Taiwan, R.O.C.
jishieh@asia.edu.tw
Kuei-Jen Lee
Department of Health and Nutrition Biotechnology
Asia University, Taichun, Taiwan, R.O.C.
kjlee@asia.edu.tw
Jing-Doo Wang
Department of Computer Science and Information Engineering
Asia University, Taichun, Taiwan, R.O.C.
jdwang@asia.edu.tw
I-Chun Chen, Am-Chou Chen, Pei-Chun Chang, and Hsiang-Chuan Liu
Department of Bioinformatics
Asia University, Taichun, Taiwan, R.O.C.
mmisssoul@gmail.com, gg.village@gmail.com, {pcchang,lhc}@asia.edu.tw
Abstract
Influenza A viruses are negative-strand RNA viruses. The
gene of hemagglutinin (HA) protein in the virus genome is the
major molecule that determining the range of hosts. Mutation of
HA gene may bring infection cross species. In this paper, we
studied physicochemical constraints during the variations of HA
gene. Fuzzy measure and Choquet integral were used to estimate
the combining effect of different physicochemical properties for
single residue in HA protein that related to infective events. With
this method, a HA sequence was quantified residue by residue
and produced a value series. Finally, the Hurst exponent was
adopted to infer the constraints in the series. We found that the
physicochemical constraints in HA sequences mainly falling into
two classes of interdependence strength during gene variation,
that were distinct from the diversity of clusters in the
phylogenetic analysis.
4. Introduction
Influenza A viruses are negative-strand RNA viruses
that infect a wide variety of animals in the nature. The
infection of human may cause significant mortality and
morbidity worldwide [1]. The gene of hemagglutinin (HA)
protein in the virus genome is the major molecule that
determining the range of hosts. The natural reservoir of
influenza virus such as avian flu may emerge in strains
infectious to human by mutation of HA gene [2,3]. Owing
to that, it is important to understand the variation nature of
HA gene. In the past, the researches in this field mainly
have been focused on the phylogenetic reconstructions
[4,5]. As shown in the explosive information on HA
sequences, the reconstruction of a phylogenetic tree can
provide abundant evolution information, and help in
understanding the drifts of influenza hosts [6]. However,
the feature and tendency about physicochemical properties
of gene variations for specific host are never been
discussed.
Fuzzy measure theory considers a number of special
classes of measurements, each of which is characterized by
a special property. In the fuzzy measure theory, the
conditions are precise, but the information about an
element alone is insufficient to determine which special
classes of measure should be used. The fuzzy measure
estimates the possible interactions among the special
classes of measurements [7]. Choquet integral is a tightly
related concept with fuzzy measure. It assesses the
integrated effect for some issue based on the concept of
fuzzy measure [7,8]. The Hurst exponent (H) is a statistical
measure used to classify time series [9]. For example,
H=0.5 indicates a random series while H>0.5 indicates a
constrained reinforcing series. The larger the H value is,
the stronger the constraint. In this paper, we studied the
physicochemical constraints of HA protein of Influenza A
(i) ν(N) = 1.
(ii) if , 2NA B with A B   then
( ) ( ) ( ) ( ) ( )A B A B A B         .
As a convention, the value of νat a singleton
set iX is called a density and is denoted by  iX .
In addition, we have that λ satisﬁes the property
 )(11
1 i
n
i
X 

(1)
Tahani and Keller [14] as well as Wang and Klir [15]
have showed that that once the densities are known, it is
possible to use the previous polynomial to obtain the
values of λ uniquely.
Definition 3. Let v be a fuzzy measure on N. The
discrete Choquet integral of function x:N→ R with respect
to v is defined by
 )()()( )1()(
1
)( 

 ii
n
i
iv AvAvxxC , where ( ‧ )
indicates a permutation on N such that
)()2()1( nxxx   . Also
 )()()( ,, nii xxA  , and )1(nA . For
instance, if 231 xxx  , then rank 321 ,, xxx from
the smallest one to the largest one. The result is 1)1( xx  ,
3)2( xx  , 2)3( xx  . Finally,
),,( 321 xxxCv =   ),,(* 3211 xxxvx +
  3213 ,(*)( xxvxx  +   )(*)( 232 xxx 
(2
)
The discrete Choquet integral takes into account the
interaction by means of the fuzzy measure v . If the
criteria are independent, the fuzzy measure is additive.
Then, the discrete Choquet integral coincides with the
weighted arithmetic mean method. That is, )(xCv =


n
i
ixiv
1
)( , nRx . In this study, the
correlation-based method proposed by Hsiang-Chuan Liu
in 2006 [16,17] to construct the fuzzy measures in the
discrete Choquet integral was used.
The Hurst exponent occurs in several areas of applied
mathematics, including fractals and chaos theories, long
memory processes and spectral analysis. Hurst exponent
estimation has been applied in areas ranging from
biophysics to computer networking. Estimation of the
Hurst exponent was originally developed in hydrology.
However, the modern techniques for estimating the Hurst
exponent come from fractal mathematics.
Estimating the Hurst exponent for a data set provides
a measure of whether the data is a pure random walk or
has underlying trends. Another way to state this is that a
random process with an underlying trend has some degree
of autocorrelation. Furthermore, when the autocorrelation
has a very long (or mathematically infinite) decay this kind
of Gaussian process is sometimes referred to as a long
memory process.
The Hurst exponent (H) is a statistical measure used
to classify time series. H=0.5 indicates a random series
while H>0.5 indicates a trend reinforcing series. The larger
the H value is, the stronger the trend. In this paper we
investigate the use of the Hurst exponent to classify series
of financial data representing different periods of time.
Experiments with back propagation Neural Networks show
that series with large Hurst exponent can be predicted
more accurately than those with H value close to 0.50.
Thus the Hurst exponent provides a measure for
predictability.
Three methods were used most often for the
estimation of the Hurst exponent: the R/S method, the
roughness–length (R–L) method and variogram. The R/S
method [18] is commonly perceived as the most suitable
for the time series analysis on the stock market or an
optimal volume of water reservoirs, because it presents the
relationship between irregular (singular) rescaled ranges,
signal value and their local statistical properties relative to
the scale factor. In this study R/S method is used. R/S
method [19] is based on empirical observations by Hurst
and estimates H are based on the R/S statistic. It indicates
(asymptotically) second-order self-similarity. H is roughly
estimated through the slope of the linear line in a log-log
plot, depicting the R/S statistics over the number of points
of the aggregated series. That is, given a time sequence of
observations tw , define the series



t
u
t wwtW
1
)(),(  , where 



  1
1
t
tww .
Define ),(min),(max)(
11


tWtWR
tt 

AvianHuman
Host
0.95
0.90
0.85
0.80
0.75
H
ur
st
ex
po
ne
nt
0.95
0.90
0.85
0.80
0.75
H
urst
exponent
800 600 400 200 0
Frequency
800600400200
Frequency
Figure 2. The frequency distribution of H3 Hurst
exponents for human strains and avian strains.
AvianHuman
Host
0.90
0.85
0.80
0.75
0.70
H
ur
st
ex
po
ne
nt
0.90
0.85
0.80
0.75
0.70
H
urst
exponent
250 200 150 100 50 0
Frequency
25020015010050
Frequency
Figure 3. The frequency distribution of H5 Hurst
exponents for human strains and avian strains.
2.5. Discussion
The gene of HA protein in the virus genome is the
major molecule that determining the range of hosts.
Basically, the infection process is physicochemical
interaction between receptor of host and HA protein. For
the sake of successful infection, the gene variations must
follow certain rules under physicochemical base. Higher
value of Hurst exponent implies more constraints or
intra-structure in the sequence properties. As to that, the
gene variations are apt to destroy the intra-structure with
high value of Hurst exponent. The variation tolerance is
different for the same serotype of HA corresponding to the
different clusters of Hurst exponents.
4. Conclusions
The constraints in HA sequences mainly fall into two
classes of Hurst strength during gene variations. That
imply the variation tolerance of HA gene is diverse in the
same serotype of HA.
Acknowledgements
This work was supported by the National Science
Council, grant no. NSC 95-2221-E-468-006-.
References
[1] P. Palese. Influenza: old and new threats. Nat. Med.,
Vol 10, pp. s82–s87, 2004.
[2] R.G. Webster, W.J. Bean, O.T. Gorman, and T.M.
Chambers, Y. Kawaoka., Evolution and ecology of
influenza A viruses. Microbiol. Rev., Vol 56, pp.
152–179, 1992.
[3] N.J. Cox and K. Subbarao. Global epidemiology of
influenza: Past and present. Annu. Rev. Med., Vol 51,
pp. 407–421, 2000.
[4] W.M. Fitch, R.M. Bush, C.A. Bender, and N.J. Cox.
Long term trends in the evolution of H(3) HA1
human influenza type A. Proc. Nat. Acad. Sci., Vol
94, pp. 7712–7718, 1997.
[5] R.M. Bush, W.M. Fitch, C.A. Bender, and N.J. Cox.
Positive selection on the H3 hemagglutiningene of
human influenza virus A. Mol. Biol. Evol., Vol 16, pp.
1457–1465, 1999.
[6] R.M. Bush, C.A. Bender, K. Subbarao, N.J. Cox, and
W.M. Fitch. Predicting the evolution of human
influenza A. Science, Vol 286, pp. 1921–1925, 1999.
[7] T. Murofushi and M. Sugeno. An interpretation of
fuzzy measure and the Choquet integral as an integral
with respect to a fuzzy measure. Fuzzy Sets and
Systems, Vol 29, pp. 201–227, 1989.
[8] T. Calvo, A. Kolesarova, M. Komornikova, and R.
Mesiar. Aggregation operators: New trends and
applications. Physica-Verlag, Springer, 2002.
[9] T. Di Matteo, T. Aste, and M.M. Dacorogna. Long
term memories of developed and emerging markets:
using the scaling analysis to characterize their stage
of development. Journal of Banking & Finance, Vol
29, pp. 827-851, 2005.
[10] D. Whitford. Proteins: structure and function. John
Wiley & Sons Ltd., 2005.
[11] T. Murofushi and M. Sugeno. An interpretation of
fuzzy measure and the Choquet integral as an integral
出 席 會 議 報 告 表
會議名稱
International Conference on Machine Learning
and Cybernetics
會議地點 中國保定
會議時
間
2009 年 7 月 12 日
12 時 00 分
會議主持
人
出席人
員 張培均
會議內容
這次的會議是以共同作者的身份前往，發表的論文是模糊測度在蛋白質耐熱性分類上的應
用，在Machine Learning的領域裡，我們提出利用模糊積分來整合四種蛋白質特徵，來預測蛋白
質的耐熱性。關於模糊測度的估計方式，本篇論文提出了四種，未來將試著應用在癌症相關生化
路徑網路交互作用上。
與會過程，獲益良多。
selecting output residue areas (POPS_R). Both the polar
(hydrophilic) and apolar (hydrophobic) surface areas can be
obtained from the output residue areas, which were then
changed to the percentage of apolar area for each residue in
a protein.
7.2. Solvent accessibility percentages
The solvent accessibility percentages of the residues
were obtained using the ASAView [4] data base
(www.netasa.org/asaview/). Residues were classified to be
buried in a protein core as the values between 0-50%, and
those were considered to be exposed to solvent when the
percentage exceeded 50%.
7.3. Electrostatic interactions
The number of ion pairs (electrostatic interactions)
was calculated according to the following criterion [4]: two
oppositely charged residues were considered an ion pair if
the distance between the oppositely charged atoms of these
residues was less than 18Å. Asp, Glu, Arg, Lys and His
residues were used to calculate the ion pairs.
7.4. Contact energies
A 20×20 matrix of effective contact energies, the
interaction energies between all amino acids pairs, was
developed by Miyazawa and Jernigan [5], [6], which was
also called MJ matrix. The MJ effective energy (eij), which
is the element of MJ matrix, was derived from all the
possible interaction energies, including hydrophobic and
solvation energies. Furthermore, the hydrophobic
interaction is the dominant contribution to the MJ effective
energy. The eij can be presented as the following equation
'
2
ii jj
ij ij
e e
e e

  (1)
The e'ij is the mixing term, which is the free energy
change upon the mixing of residues of type i and residues
of type j when the contacts in self-pairs i-i and j-j are
separated to form i-j pairs. The eii or ejj is the free energy
change after the desolvation of residue i or of residue j to
form the self-pairs i-i or j-j. The values of eii or ejj should
have high correlation with the hydrophobicity of residue
type i or residue type j [5], [6].
The average contact energy of each type of amino acid,
ei, was used in this work, and it is defined as: [5], [6].
20
1
ij ij
j
i
ir
e N
e
N


(2)
where
;ij ij p
p
N n (3)
and
0
ir ij
j
n n

 (4)
The supscript p denotes the total number of contacts in
all proteins, nij is the total number of contacts between i and
j types of amino acid residues, and nir is the total number
contacts made by residue type i.
8. Hurst exponent
The Hurst exponent (H) is a statistical measure used to
classify time series for long term memory and predictability
[7].
In this study, R/S method is used for the estimation of
the Hurst exponent: R/S method [8],[9] is based on
empirical observations by Hurst in 1965 and estimates H
are based on the R/S statistic. It indicates (asymptotically)
second-order self-similarity. H is roughly estimated through
the slope of the linear line in a log-log plot, depicting the
R/S statistics over the number of points of the aggregated
series. That is, given a time sequence of observations, tw
define the Series
   
1
, , 1
t
u
u
W t w w t 

    (5)
where
1
1
t
t
w w

 
  (6)
Define
11
( ) max ( , ) min ( , )
tt
R W t W t
 
  

  (7)
and
 2
1
1
( ) t
t
S w w

 
     (8)
In plotting ( )log
( )
R
S


against log, we expect to get a
line whose slope determines the Hurst exponent.
9. The multiple linear regression, ridge regression
Let  2, ~ N 0, nY X I     be a multiple linear
model,  1ˆ X X X Y   be the estimated regression
1 1
1 1ˆˆ
N N
i i
i i
y f dg
N N 
 
 
   (26)
12. Experiment and result
A thermostable proteins data set is provided by the
Protein Data Bank (PDB), http://www.rcsb.org/. There are
40 instances with two classes. Substituting four
physicochemical quantities, solvent-accessible surface area,
solvent accessibility percentage, electrostatic interaction,
and contact energy, for each residue of amino acid in
sequence of the thermostable proteins by using the four
feature scaling estimators, we can obtained four
non-symbolic sequences of the thermostable proteins.
Computing the Hurst exponents of each non-symbolic
sequences of the thermostable proteins, we can obtain four
features represented as Hurst exponents respectively in each
sequences of the thermostable protein. The transformed
data is listed in Table 2.
The generated data with four features in terms of Hurst
exponents is applied to evaluate the leave-one-out
classification accuracies of three classifiers: the Choquet
integral regression, SVM, and the multiple linear regression
by using 5-fold Cross-Validation MSE.
The experimental results are listed in Table 1. We can
find that the Choquet integral regression model based on
L-measure has the best performance.
Table 1 : MSE of prediction models
HE-Prediction models 5-fold CV MSE
HE-Choquet Integral
Regression model with
L-measure
14.9257
HE-Choquet Integral
Regression model with
P-measure
15.2290
HE-Choquet Integral
Regression model with
λ-measure
15.3812
HE- Ridge regression model 16.3311
HE-Multiple linear regression
model 19.7055
13. Conclusions and future works
In this paper, a novel classification algorithm of
thermostable proteins combining four feature scaling
estimators, Hurst exponent, and the Choquet integral
regression model is proposed. For evaluating the
performance of this new algorithm, a thermostable proteins
data set by using leave-one-out classification accuracy is
conducted. Experimental result shows that this new
prediction algorithm is useful and better than the traditional
two prediction models.
In future, we will consider looking for some improving
prediction algorithm of thermostable proteins by using
Hurst exponent and other prediction models.
14. Acknowledgements
This paper is partially supported by the National
Science Council grant (NSC 97-2410--H-468-014).
References
[20] Protein Data Bank (PDB), http://www.rcsb.org/.
[21] Franca Fealernali and Luigi Cavalo, “Parameter 
optimized surfaces (POPS): analysis of key
interactions and conformational changes in the
ribosome”, Nucleic Acids Reasearch, 2002, Vol. 30, 
No 13, pp. 2950-2960, Oxford University press.
[22] Luigi Cavallo, Jens Kleinjung and Franca Fraternali,
“POPS: a fast algorithm for solvent accessible surface
areas at atomic and residue level”, Nucleic Acids 
Reasearch, 2003, Vol. 31. No.13, pp. 3364-3366.
DOI:10.1093/nar/gkg601.
[23] S. Ahmad, M. Gromiha, H. Fawareh, “A. Sarai, 
ASAView: Database and tool for solvent accessibility
representation in proteins”, BMC bioinformatics, 2004, 
Vol. 5, pp. 51-55.
[24] A. Szilagyi, and P. Zavodszky, “Structural differences 
between mesophilic, moderately thermophilic and
extremely thermophilic protein subunits: results of a
comprehensive survey”, Structure Folding and Design,
2000, Vol. 8, 493-504.
[25] S. Miyazawa, R. L. Jernigan, “Estimation of effective 
interresidue contact energies from protein crystal
structures: quasi-chemical approximation”, 
Macromolecules, 1985, Vol. 18, pp. 534-552.
[26] H. E. Hurst: “Long term storage capacity of 
reservoirs”, Transactions of the American Society of 
Civil Engineers, 1951, Vol.116, pp. 770-799.
[27] H. E. Hurst, R. Black, and Y. M. Sinaika, ”Long term 
storage capacity of reservoirs”, An experimental study 
Constable, London, 1965.
[28] Hsiang-Chuan Liu, Horng-jinh Chang, Kuei-Jen Lee,
Jiunn-I Shieh, Wen-Chun Huang, Shin-Ming Huang
“A Novel Classification Algorithm of Thermostable 
Proteins by Using Hurst Exponent and SVM
Classifier”, Proceedings of the 4th International 
Conferences on Natural Computation, Jinan,
